Margaret Pax
Director/Board Member at ALIMERA SCIENCES, INC.
Net worth: 118 228 $ as of 30/05/2024
Profile
Margaret A Pax is currently an Independent Director at Alimera Sciences, Inc., a Director at Bioporto, Inc., an Independent Director at Repligen Corp., and an Independent Director at Jellagen Pty Ltd.
Previously, she worked as a Director at Bioporto A, Vice President-Marketing at OmniSonics Medical Technologies, Inc., and Vice President-Business Development at Microchips Biotech, Inc. Ms. Pax holds an MBA from Harvard University, an undergraduate degree from the College of the Holy Cross (Massachusetts), and another MBA from Harvard Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
REPLIGEN CORPORATION
0.00% | 15/05/2024 | 793 ( 0.00% ) | 118 228 $ | 30/05/2024 |
ALIMERA SCIENCES, INC.
-.--% | 23/04/2024 | 0 ( -.--% ) | - $ | 30/05/2024 |
Margaret Pax active positions
Companies | Position | Start |
---|---|---|
ALIMERA SCIENCES, INC. | Director/Board Member | 07/11/2023 |
REPLIGEN CORPORATION | Director/Board Member | 17/03/2024 |
Bioporto, Inc. | Director/Board Member | - |
Jellagen Pty Ltd.
Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Jellagen Pty Ltd. produces research grade functional non-mammalian collagen products. The company was founded by Andrew Mearns Spragg and Alex Muhlholzl in May 2013 and is headquartered in Pembroke Dock, the United Kingdom. | Director/Board Member | - |
Harvard Business School Health Industry Alumni Association | Director/Board Member | - |
Former positions of Margaret Pax
Companies | Position | End |
---|---|---|
OmniSonics Medical Technologies, Inc.
OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology OmniSonics Medical Technologies, Inc. developed medical catheter based thrombectomy device. It used to transverse ultrasound technology to remove thrombus and enhance the dispersion of physician specified fluids in the peripheral vasculature. The company was founded by Robert Rabiner and was headquartered in Lakewood, NY. | Sales & Marketing | - |
BIOPORTO A/S | Director/Board Member | - |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Microchips Biotech, Inc. develops drug delivery systems and bio sensing devices. Its technologies are designed to transform electromechanical medical devices into highly tuned biochemical sensing and therapy systems. The company was founded by Terrance G. McGuire, Michael J. Cima, John T. Santini, Jr. and Robert S. Langer, Jr. in 1999 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Training of Margaret Pax
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
REPLIGEN CORPORATION | Health Technology |
ALIMERA SCIENCES, INC. | Health Technology |
BIOPORTO A/S | Health Technology |
Private companies | 5 |
---|---|
OmniSonics Medical Technologies, Inc.
OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology OmniSonics Medical Technologies, Inc. developed medical catheter based thrombectomy device. It used to transverse ultrasound technology to remove thrombus and enhance the dispersion of physician specified fluids in the peripheral vasculature. The company was founded by Robert Rabiner and was headquartered in Lakewood, NY. | Health Technology |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Microchips Biotech, Inc. develops drug delivery systems and bio sensing devices. Its technologies are designed to transform electromechanical medical devices into highly tuned biochemical sensing and therapy systems. The company was founded by Terrance G. McGuire, Michael J. Cima, John T. Santini, Jr. and Robert S. Langer, Jr. in 1999 and is headquartered in Lexington, MA. | Health Technology |
Harvard Business School Health Industry Alumni Association | |
Jellagen Pty Ltd.
Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Jellagen Pty Ltd. produces research grade functional non-mammalian collagen products. The company was founded by Andrew Mearns Spragg and Alex Muhlholzl in May 2013 and is headquartered in Pembroke Dock, the United Kingdom. | Consumer Non-Durables |
Bioporto, Inc. |
- Stock Market
- Insiders
- Margaret Pax